DexCom (DXCM) stock Forecast for 2022 – 2026
Last update: 05-24-2022, 6:38
Sector: HealthcareThe share price of DexCom, Inc. (DXCM) now
What analysts predict:: $546.94
52-week high/low: $659.45 / $302.61
50/200 Day Moving Average: $440.31 / $501.01
This figure corresponds to the average price over the previous 50/200 days. For DexCom stocks, the 50-day moving average is the resistance level today.
For DexCom stocks, the 200-day moving average is the resistance level today.
Are you interested in DexCom, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the DexCom stock price in 2022, 2023, 2024, 2025, 2026. How much will one DexCom share be worth in 2022 - 2026?
When should I take profit in DexCom stock? When should I record a loss on DexCom stock? What are analysts' forecasts for DexCom stock? What is the future of DexCom stock?
We forecast DexCom stock performance using neural networks based on historical data on DexCom stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
DexCom stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for DexCom shares. This happens once a day.
Historical and forecast chart of DexCom stock
The chart below shows the historical price of DexCom stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the DexCom stock price can be found in the table below.
Long-term forecasts by years.
DexCom daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 330.65 | 328.43 | 335.37 | 2.11 |
| May 27 | 327.22 | 322.82 | 334.19 | 3.52 |
| May 28 | 329.15 | 325.46 | 333.94 | 2.61 |
| May 29 | 330.35 | 327.76 | 336.26 | 2.60 |
| May 30 | 333.30 | 327.33 | 336.48 | 2.79 |
| May 31 | 341.14 | 333.69 | 346.78 | 3.92 |
| Jun 01 | 340.09 | 334.38 | 344.28 | 2.96 |
| Jun 02 | 340.38 | 333.61 | 342.38 | 2.63 |
| Jun 03 | 330.85 | 326.22 | 336.50 | 3.15 |
| Jun 04 | 332.24 | 325.82 | 337.08 | 3.45 |
| Jun 05 | 323.68 | 319.51 | 329.30 | 3.06 |
| Jun 06 | 325.95 | 322.93 | 332.24 | 2.88 |
| Jun 07 | 330.97 | 325.78 | 334.86 | 2.79 |
| Jun 08 | 328.37 | 323.96 | 330.85 | 2.13 |
| Jun 09 | 325.70 | 320.60 | 332.82 | 3.81 |
| Jun 10 | 321.69 | 318.90 | 325.11 | 1.95 |
| Jun 11 | 319.44 | 313.72 | 322.84 | 2.91 |
| Jun 12 | 323.91 | 318.47 | 329.08 | 3.33 |
| Jun 13 | 314.93 | 312.20 | 319.52 | 2.34 |
| Jun 14 | 314.23 | 307.28 | 317.31 | 3.26 |
| Jun 15 | 317.48 | 311.44 | 324.51 | 4.20 |
| Jun 16 | 313.93 | 308.30 | 316.04 | 2.51 |
| Jun 17 | 320.34 | 317.65 | 322.23 | 1.44 |
| Jun 18 | 326.08 | 319.51 | 329.64 | 3.17 |
| Jun 19 | 330.74 | 326.57 | 333.89 | 2.24 |
| Jun 20 | 334.54 | 329.20 | 338.94 | 2.96 |
| Jun 21 | 333.60 | 331.36 | 339.11 | 2.34 |
| Jun 22 | 325.75 | 322.20 | 331.23 | 2.80 |
| Jun 23 | 324.57 | 321.75 | 330.93 | 2.85 |
| Jun 24 | 323.21 | 319.77 | 326.19 | 2.01 |
DexCom Daily Price Targets
DexCom Stock Forecast 05-26-2022.
Pessimistic target level: 328.43
Optimistic target level: 335.37
DexCom Stock Forecast 05-27-2022.
Pessimistic target level: 322.82
Optimistic target level: 334.19
DexCom Stock Forecast 05-28-2022.
Pessimistic target level: 325.46
Optimistic target level: 333.94
DexCom Stock Forecast 05-29-2022.
Pessimistic target level: 327.76
Optimistic target level: 336.26
DexCom Stock Forecast 05-30-2022.
Pessimistic target level: 327.33
Optimistic target level: 336.48
DexCom Stock Forecast 05-31-2022.
Pessimistic target level: 333.69
Optimistic target level: 346.78
DXCM (DXCM) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 336.68 | 318.09 | 354.19 | 10.19 |
| Jul. | 358.76 | 347.57 | 369.10 | 5.83 |
| Aug. | 357.62 | 349.61 | 373.06 | 6.29 |
| Sep. | 336.16 | 316.26 | 353.37 | 10.50 |
| Oct. | 349.07 | 334.55 | 360.24 | 7.13 |
| Nov. | 350.46 | 330.00 | 356.91 | 7.54 |
| Dec. | 355.51 | 333.90 | 372.86 | 10.45 |
DexCom forecast for this year
DexCom Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $336.677. Pessimistic: $318.09. Optimistic: $354.19
DexCom Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $358.763. Pessimistic: $347.57. Optimistic: $369.10
DexCom Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $357.615. Pessimistic: $349.61. Optimistic: $373.06
DexCom Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $336.158. Pessimistic: $316.26. Optimistic: $353.37
DexCom Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $349.067. Pessimistic: $334.55. Optimistic: $360.24
DexCom Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $350.463. Pessimistic: $330.00. Optimistic: $356.91
DexCom Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $355.51. Pessimistic: $333.90. Optimistic: $372.86
DexCom (DXCM) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 362.62 | 347.54 | 376.55 | 7.70 |
| Feb | 353.05 | 336.38 | 362.09 | 7.10 |
| Mar | 377.62 | 369.16 | 397.56 | 7.14 |
| Apr | 368.25 | 355.59 | 378.27 | 6.00 |
| May | 372.38 | 366.42 | 378.93 | 3.30 |
| Jun | 394.42 | 374.23 | 418.72 | 10.63 |
| Jul | 424.72 | 409.77 | 435.25 | 5.85 |
| Aug | 455.29 | 434.53 | 470.59 | 7.66 |
| Sep | 466.59 | 439.34 | 489.73 | 10.29 |
| Oct | 478.90 | 459.36 | 491.93 | 6.62 |
| Nov | 515.30 | 486.86 | 535.50 | 9.08 |
| Dec | 542.51 | 533.83 | 567.25 | 5.89 |
DexCom (DXCM) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 556.83 | 534.56 | 588.01 | 9.09 |
| Feb | 514.07 | 492.68 | 531.34 | 7.28 |
| Mar | 505.84 | 486.42 | 532.95 | 8.73 |
| Apr | 519.20 | 503.41 | 540.79 | 6.91 |
| May | 524.18 | 502.79 | 556.47 | 9.65 |
| Jun | 541.79 | 524.02 | 573.00 | 8.55 |
| Jul | 577.77 | 556.51 | 605.04 | 8.02 |
| Aug | 556.04 | 528.46 | 571.17 | 7.48 |
| Sep | 561.38 | 551.05 | 581.14 | 5.18 |
| Oct | 558.69 | 546.62 | 583.72 | 6.36 |
| Nov | 569.41 | 539.80 | 596.29 | 9.47 |
| Dec | 572.15 | 535.99 | 591.83 | 9.44 |
DexCom (DXCM) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 550.18 | 522.89 | 562.94 | 7.11 |
| Feb | 536.09 | 509.50 | 562.68 | 9.45 |
| Mar | 575.55 | 559.89 | 611.00 | 8.36 |
| Apr | 556.21 | 528.62 | 570.45 | 7.33 |
| May | 554.87 | 522.03 | 567.75 | 8.05 |
| Jun | 578.40 | 553.88 | 605.70 | 8.56 |
| Jul | 619.12 | 602.78 | 647.85 | 6.96 |
| Aug | 627.54 | 597.42 | 659.17 | 9.37 |
| Sep | 636.58 | 620.79 | 661.02 | 6.09 |
| Oct | 643.71 | 615.90 | 668.94 | 7.93 |
| Nov | 633.41 | 623.27 | 667.86 | 6.68 |
| Dec | 615.17 | 594.99 | 633.37 | 6.06 |
DexCom (DXCM) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 657.00 | 638.08 | 681.70 | 6.40 |
| Feb | 636.50 | 607.98 | 658.90 | 7.73 |
| Mar | 651.27 | 612.19 | 690.34 | 11.32 |
| Apr | 659.60 | 621.08 | 680.71 | 8.76 |
| May | 654.85 | 636.52 | 684.19 | 6.97 |
| Jun | 687.86 | 656.49 | 706.02 | 7.01 |
| Jul | 708.22 | 684.99 | 753.54 | 9.10 |
| Aug | 722.38 | 708.51 | 752.43 | 5.84 |
| Sep | 689.44 | 650.83 | 701.58 | 7.23 |
| Oct | 697.71 | 670.92 | 727.30 | 7.75 |
| Nov | 682.09 | 667.90 | 723.56 | 7.69 |
| Dec | 643.89 | 615.56 | 675.31 | 8.85 |
DexCom information and performance
Dexcom, Inc. is a medical equipment company. The company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare professionals. Its products include Dexcom G6 and Dexcom stake. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which can include automated insulin dosing systems, insulin pumps, blood glucose meters, or other electronic devices used to treat diabetes. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on a patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transfer glucose information to the cloud and then to apps on mobile devices to up to five designated recipients who can remotely monitor patient glucose information and receive alerts.
DexCom Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA, US
Market Capitalization: 32 593 500 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 361 100 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 169.82
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 2.188
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 1.956
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.678
Quarterly Revenue Growth YOY: 0.245
Trailing PE: 169.82
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 102.04
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 12.56
Enterprise Value (EV) /Revenue
EV To EBITDA: 82.97
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 98126000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A